Friday 6 November 2026 Export GKOS’s income statement to Excel — free account

Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.

Revenue: +58.0%
EPS: +112.2%
Free cash flow: +411.2%
Total debt: −2.25%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

224.21 4.23 +1.92%

Follow GKOS

Alert me

Market cap: $13.0B
P/E: 0.0×
Fwd P/E: −803×
Dividend yield: —
F-score: 3/9
Altman Z: 15.20
Beneish M: −2.96
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Glaukos Corporation 10-K filed Feb 23, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed Feb 23, 2026 · accepted 7:54 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1A, Risk Factors, against the 10-K filed Feb 25, 2025: 6 added · 4 removed · 68 modified; 3 with only figures updated